| Authors: |
Roca CP; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Burton OT; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Neumann J; VIB Center for Brain and Disease Research, 3000 Leuven, Belgium.; KU Leuven - University of Leuven, Department of Microbiology and Immunology, 3000 Leuven, Belgium., Tareen S; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Whyte CE; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Gergelits V; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Veiga RV; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Humblet-Baron S; VIB Center for Brain and Disease Research, 3000 Leuven, Belgium., Liston A; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK. |